OM-89 [Uro-Vaxom® Capsule]

DRUG2 trials

Sponsors

AJU Pharm Co., Ltd., Centre Hospitalier Universitaire Dijon

Conditions

Chronic Pelvic Pain SyndromeChronic ProstatitisChronic Prostatitis With Chronic Pelvic Pain SyndromeNeurogenic Bladder

Phase 3

Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary Tract Infections in Patients With Neurogenic Bladder

RecruitingNCT06588010

Centre Hospitalier Universitaire DijonNeurogenic Bladder

Start: 2024-12-16End: 2029-12-01Target: 110Updated: 2026-09-08

Phase 4

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

RecruitingNCT06345014

AJU Pharm Co., Ltd.Chronic Pelvic Pain Syndrome, Chronic Prostatitis, Chronic Prostatitis With Chronic Pelvic Pain Syndrome

Start: 2023-12-20End: 2026-03-30Target: 332Updated: 2024-04-04